Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Assistance Publique-Hopitaux De Paris (Ap-Hp) is managing a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The current prosecution data shows 1 pending office action, which is being handled by 1 distinct examiner. This activity is occurring within a single distinct art unit, reflecting a very specific and concentrated technical focus for the organization's current pending matters. This suggests that the organization's active patenting efforts are currently limited to a single specialized area of biotechnology.
The busiest examiner for this portfolio is NEAGU, IRINA, who is overseeing a single pending office action. This examiner is responsible for the entire pending workload currently reported for the organization in the Biotechnology & Pharmaceuticals sector. With only a single pending action and a single examiner, the organization's immediate patenting efforts are focused on a single point of review, which simplifies the administrative tracking but concentrates the prosecution risk on a single examiner's interpretation. For the applicant, the success of this pending matter will depend heavily on navigating the specific requirements and examination style of this individual within the identified art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NEAGU, IRINA | 1 | 46.7% | +57.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18662943 | METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT | NEAGU, IRINA | — |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18662943 | METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT | NEAGU, IRINA | 1629 | §103DP | Non-Final OA | — | Pending | May 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAssistance Publique-Hopitaux De Paris (Ap-Hp) has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Irina Neagu has the most, with 1 of Assistance Publique-Hopitaux De Paris (Ap-Hp)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
